Team

Under the guidance of the Board of Directors, SARC’s policies and strategies are established and refined on a regular basis. Our board consists of individuals from a range of backgrounds and areas of expertise to ensure that different viewpoints are represented as strategies are crafted to support SARC’s mission. The board meets quarterly, and as needed, to conduct the important business of SARC.

The purpose of SARC’s Clinical Trialist Group is to generate Sarcoma clinical trial proposals, to support young investigators in developing and submitting trials concepts, and to engage clinical trialists and industry to pursue clinical trials in sarcoma.

SARC’s Discovery/Translation Committee’s mandate is to expand SARC’s commitment to discovery and translational sciences. One of the Committee’s most immediate goals is to integrate more science in each SARC clinical trial, explaining why new therapies help some people and not others – this will enable SARC refine the therapeutic approaches, helping more people and reducing needless treatment toxicity.

The SARC Multidisciplinary Tumor Board (SMTB) is a team of experts from a wide range of specialties that meet monthly for in-depth, evidence-based discussion of tumor diagnosis and management. More about SMTB

The SARC Research Advocacy Council (RAC) was created using the model established by the National Cancer Institute (NCI) for engagement of patient advocates to become “research advocates” across four key functions: advise, design, review, and disseminate. A number of individual patient advocates have agreed to serve as research advocates on the SARC Research Advocacy Council. The council convenes regularly to explore opportunities to interface with researchers. More about RAC

The team of individuals at SARC’s operations office provides the range of expertise needed to support the organization’s scientific leadership and sustain the infrastructure necessary to facilitate the conduct of research.